BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36685074)

  • 1. Arenobufagin causes ferroptosis in human gastric cancer cells by increasing rev-erbα expression.
    Chen K; Li A; Wang J; Li D; Wang X; Liu C; Wang Z
    J Tradit Complement Med; 2023 Jan; 13(1):72-80. PubMed ID: 36685074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Nrf2 reverses ferroptosis induced by Arenobufagin in gastric cancer.
    Long J; Wang W; Chu J; Li Y; Wang M; Su J; Yang Y; Wang G; Li Q; Cheng H
    Toxicol Appl Pharmacol; 2024 Mar; 484():116842. PubMed ID: 38307257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arenobufagin increases the sensitivity of gastric cancer to cisplatin via alkaliptosis.
    Liu C; Li D; Wang J; Wang Z
    Heliyon; 2023 Nov; 9(11):e21110. PubMed ID: 37920505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arenobufagin modulation of PCSK9-mediated cholesterol metabolism induces tumor-associated macrophages polarisation to inhibit hepatocellular carcinoma progression.
    Li Y; Chen Y; Zhao C; Yang Y; Zhang M; Cheng H; Li Q; Wang M
    Phytomedicine; 2024 Jun; 128():155532. PubMed ID: 38493722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting Rev-erbα-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes.
    Huang Q; Tian H; Tian L; Zhao X; Li L; Zhang Y; Qiu Z; Lei S; Xia Z
    Free Radic Biol Med; 2023 Nov; 209(Pt 1):135-150. PubMed ID: 37805047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rev-erbα inhibits proliferation by reducing glycolytic flux and pentose phosphate pathway in human gastric cancer cells.
    Tao L; Yu H; Liang R; Jia R; Wang J; Jiang K; Wang Z
    Oncogenesis; 2019 Oct; 8(10):57. PubMed ID: 31591390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo.
    Lv J; Lin S; Peng P; Cai C; Deng J; Wang M; Li X; Lin R; Lin Y; Fang A; Li Q
    Onco Targets Ther; 2017; 10():1261-1267. PubMed ID: 28280360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lipid homeostasis regulation study of arenobufagin in zebrafish HepG2 xenograft model and HepG2 cells using integrated lipidomics-proteomics approach.
    Zhao LJ; Zhao HY; Wei XL; Guo FF; Wei JY; Wang HJ; Yang J; Yang ZG; Si N; Bian BL
    J Ethnopharmacol; 2020 Oct; 260():112943. PubMed ID: 32422359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicokinetics of Arenobufagin and its Cardiotoxicity Mechanism Exploration Based on Lipidomics and Proteomics Approaches in Rats.
    Zhao L; Han L; Wei X; Zhou Y; Zhang Y; Si N; Wang H; Yang J; Bian B; Zhao H
    Front Pharmacol; 2021; 12():780016. PubMed ID: 35002716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of REV-ERBα dysregulation and ferroptosis in aristolochic acid I-induced renal injury.
    Wang Y; Wang Z; Wu Z; Chen M; Dong D; Yu P; Lu D; Wu B
    Biochem Pharmacol; 2021 Nov; 193():114807. PubMed ID: 34673015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REV-ERBα reduction is associated with clinicopathological features and prognosis in human gastric cancer.
    Wang X; Wang N; Wei X; Yu H; Wang Z
    Oncol Lett; 2018 Aug; 16(2):1499-1506. PubMed ID: 30008829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of REV-ERBα represses LPS-induced microglial activation through the NF-κB pathway.
    Guo DK; Zhu Y; Sun HY; Xu XY; Zhang S; Hao ZB; Wang GH; Mu CC; Ren HG
    Acta Pharmacol Sin; 2019 Jan; 40(1):26-34. PubMed ID: 29950615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational Modifications of Rev-Erb
    Ke C; Xiaowen C; Yufeng W; Dongchang L; Huaqing Z; Zhengguang W
    J Oncol; 2022; 2022():6291656. PubMed ID: 36618075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
    Guan Z; Chen J; Li X; Dong N
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruscogenin Prevents Folic Acid-Induced Acute Kidney Damage by Inhibiting Rev-erb
    Hu M; An S
    Comput Intell Neurosci; 2022; 2022():8066126. PubMed ID: 35845882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori-Induced Rev-erbα Fosters Gastric Bacteria Colonization by Impairing Host Innate and Adaptive Defense.
    Mao FY; Lv YP; Hao CJ; Teng YS; Liu YG; Cheng P; Yang SM; Chen W; Liu T; Zou QM; Xie R; Xu JY; Zhuang Y
    Cell Mol Gastroenterol Hepatol; 2021; 12(2):395-425. PubMed ID: 33676046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rev-erbα Inhibits Proliferation and Promotes Apoptosis of Preadipocytes through the Agonist GSK4112.
    Chu G; Zhou X; Hu Y; Shi S; Yang G
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BID links ferroptosis to mitochondrial cell death pathways.
    Neitemeier S; Jelinek A; Laino V; Hoffmann L; Eisenbach I; Eying R; Ganjam GK; Dolga AM; Oppermann S; Culmsee C
    Redox Biol; 2017 Aug; 12():558-570. PubMed ID: 28384611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer.
    Liu Y; Song Z; Liu Y; Ma X; Wang W; Ke Y; Xu Y; Yu D; Liu H
    Acta Pharm Sin B; 2021 Jun; 11(6):1513-1525. PubMed ID: 34221865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.